BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22884577)

  • 1. Conjugation of cyclodextrin with fullerene as a new class of HCV entry inhibitors.
    Xiao SL; Wang Q; Yu F; Peng YY; Yang M; Sollogoub M; Sinaÿ P; Zhang YM; Zhang LH; Zhou DM
    Bioorg Med Chem; 2012 Sep; 20(18):5616-22. PubMed ID: 22884577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and biological evaluation of water-soluble per-O-methylated cyclodextrin-C
    Zhu X; Xiao S; Zhou D; Sollogoub M; Zhang Y
    Eur J Med Chem; 2018 Feb; 146():194-205. PubMed ID: 29407950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and anti-HCV entry activity studies of β-cyclodextrin-pentacyclic triterpene conjugates.
    Xiao S; Wang Q; Si L; Shi Y; Wang H; Yu F; Zhang Y; Li Y; Zheng Y; Zhang C; Wang C; Zhang L; Zhou D
    ChemMedChem; 2014 May; 9(5):1060-70. PubMed ID: 24623716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of bivalent oleanane-type triterpenes as potent HCV entry inhibitors.
    Yu F; Peng Y; Wang Q; Shi Y; Si L; Wang H; Zheng Y; Lee E; Xiao S; Yu M; Li Y; Zhang C; Tang H; Wang C; Zhang L; Zhou D
    Eur J Med Chem; 2014 Apr; 77():258-68. PubMed ID: 24650713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and hepatitis C antiviral activity of 1-aminobenzyl-1H-indazole-3-carboxamide analogues.
    Shi JJ; Ji FH; He PL; Yang YX; Tang W; Zuo JP; Li YC
    ChemMedChem; 2013 May; 8(5):722-5. PubMed ID: 23512654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity studies of (-)-epigallocatechin gallate derivatives as HCV entry inhibitors.
    Bhat R; Adam AT; Lee JJ; Deloison G; Rouillé Y; Séron K; Rotella DP
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4162-5. PubMed ID: 25103601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and anti-HCV activity of thiourea compounds.
    Kang IJ; Wang LW; Lee CC; Lee YC; Chao YS; Hsu TA; Chern JH
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1950-5. PubMed ID: 19251415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of oleanane-type triterpenes as a new class of HCV entry inhibitors.
    Yu F; Wang Q; Zhang Z; Peng Y; Qiu Y; Shi Y; Zheng Y; Xiao S; Wang H; Huang X; Zhu L; Chen K; Zhao C; Zhang C; Yu M; Sun D; Zhang L; Zhou D
    J Med Chem; 2013 Jun; 56(11):4300-19. PubMed ID: 23662817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Alkyloxazoles as potent and selective PI4KIIIβ inhibitors demonstrating inhibition of HCV replication.
    Keaney EP; Connolly M; Dobler M; Karki R; Honda A; Sokup S; Karur S; Britt S; Patnaik A; Raman P; Hamann LG; Wiedmann B; LaMarche MJ
    Bioorg Med Chem Lett; 2014 Aug; 24(16):3714-8. PubMed ID: 25065492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 2'-fluoro and 2',4'-dimethyl pyrimidine C-nucleoside analogues as potential anti-HCV agents.
    Liu LJ; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2010 Mar; 29(3):216-27. PubMed ID: 20408052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antiviral activity of a novel class of (5-oxazolyl)phenyl amines.
    Zhong ZJ; Zhang DJ; Peng ZG; Li YH; Shan GZ; Zuo LM; Wu LT; Li SY; Gao RM; Li ZR
    Eur J Med Chem; 2013 Nov; 69():32-43. PubMed ID: 23999140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of ring A and/or C expansion and opening echinocystic acid derivatives for anti-HCV entry inhibitors.
    Wang H; Yu F; Peng Y; Wang Q; Han X; Xu R; Zhou X; Wan C; Fan Z; Jiao P; Zhang Y; Zhang L; Zhou D; Xiao S
    Eur J Med Chem; 2015 Sep; 102():594-9. PubMed ID: 26318066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectrophotometric study of fluorescence sensing and selective binding of biochemical substrates by 2,2'-bridged bis(beta-cyclodextrin) and its water-soluble fullerene conjugate.
    Liu Y; Liang P; Chen Y; Zhao YL; Ding F; Yu A
    J Phys Chem B; 2005 Dec; 109(49):23739-44. PubMed ID: 16375355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and characterization of a novel 7-aminopyrazolo[1,5-a]pyrimidine analog as a potent hepatitis C virus inhibitor.
    Hwang JY; Windisch MP; Jo S; Kim K; Kong S; Kim HC; Kim S; Kim H; Lee ME; Kim Y; Choi J; Park DS; Park E; Kwon J; Nam J; Ahn S; Cechetto J; Kim J; Liuzzi M; No Z; Lee J
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7297-301. PubMed ID: 23159569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-D-2'-α-F-2'-β-C-Methyl-6-O-substituted 3',5'-cyclic phosphate nucleotide prodrugs as inhibitors of hepatitis C virus replication: a structure-activity relationship study.
    Du J; Bao D; Chun BK; Jiang Y; Reddy PG; Zhang HR; Ross BS; Bansal S; Bao H; Espiritu C; Lam AM; Murakami E; Niu C; Micolochick Steuer HM; Furman PA; Otto MJ; Sofia MJ
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5924-9. PubMed ID: 22892115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aqueous solubilization of fullerenes using poly(amidoamine) dendrimers bearing cyclodextrin and poly(ethylene glycol).
    Kojima C; Toi Y; Harada A; Kono K
    Bioconjug Chem; 2008 Nov; 19(11):2280-4. PubMed ID: 18844391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antiviral activity of cyclopropyl-spirocarbocyclic adenosine, (4R,5S,6R,7R)-4-(6-amino-9H-purin-9-yl)-7-(hydroxymethyl)spiro[2.4]heptane-5,6-diol against hepatitis C virus.
    Gadthula S; Rawal RK; Sharon A; Wu D; Korba B; Chu CK
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3982-5. PubMed ID: 21621997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytostatic and antiviral 6-arylpurine ribonucleosides. Part 7: synthesis and evaluation of 6-substituted purine l-ribonucleosides.
    Hocek M; Silhár P; Shih IH; Mabery E; Mackman R
    Bioorg Med Chem Lett; 2006 Oct; 16(20):5290-3. PubMed ID: 16905315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyanion inhibitors of HIV and other viruses. 7. Polyanionic compounds and polyzwitterionic compounds derived from cyclodextrins as inhibitors of HIV transmission.
    Leydet A; Moullet C; Roque JP; Witvrouw M; Pannecouque C; Andrei G; Snoeck R; Neyts J; Schols D; De Clercq E
    J Med Chem; 1998 Dec; 41(25):4927-32. PubMed ID: 9836609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of ASP5286: A novel non-immunosuppressive cyclophilin inhibitor for the treatment of HCV.
    Makino T; Yoshimura S; Neya M; Yamanaka T; Sawada M; Tsujii E; Barrett D
    Bioorg Med Chem Lett; 2020 Aug; 30(16):127308. PubMed ID: 32631528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.